Researchers at Amsterdam UMC, Netherlands, used CRISPR-Cas9 to eliminate HIV from infected cells in a study, targeting conserved viral genome sections.
Researchers at Amsterdam UMC, Netherlands, have demonstrated the potential to eliminate HIV from infected cells using CRISPR-Cas9 gene editing technology. The study, led by Dr. Elena Herrera-Carrillo, targeted conserved sections of the virus genome, aiming for a broad-spectrum therapy effective against multiple strains. While the study represents proof of concept, further work is needed to optimize the delivery route and ensure safety before moving towards human clinical trials.
March 19, 2024
21 Articles